MBX Biosciences, Inc. (MBX) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$79.95M | -46.2% |
| 2024 | -$54.68M | -71.0% |
| 2023 | -$31.98M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$79.95M | -46.2% |
| 2024 | -$54.68M | -71.0% |
| 2023 | -$31.98M | — |